C12Q 2541/00
Reactions characterised by directed evolution
C12Q2541/00 (Reactions characterised by directed evolution) appears on 8 US grants and 8 published applications in this corpus.
Search patents in C12Q- Granted patents
- 8
- Published applications
- 8
- Assignees
- 8
- Inventors
- 25
- Latest grant
- 5 Apr 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 1 | 0 |
| 2022 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Method and kit for simultaneous detection of multi target molecules using magnetic bead-aptamer conjugate5 Apr 2022US 11,293,918 B2
- Methods for screening nucleic acid aptamers13 Apr 2021US 10,975,370 B2Linkbio Co., Ltd.
- Screening of nucleic acid agents via particle display31 Jul 2018US 10,036,008 B2The Regents of the University of California
- Library compositions and methods for acyclic identification of aptamers24 Nov 2015US 9,193,968 B2Aptamatrix, Inc.
- Tenascin-C nucleic acid ligands22 Jul 2003US 6,596,491 B2Gilead Sciences, Inc.
- Methods for screening nucleic acid aptamers22 Oct 2020US 2020/0332281 A1Nissan Chemical Corporation
- Method and kit for simultaneous detection of multi target molecules using magnetic bead-aptamer conjugate16 Apr 2020US 2020/0116711 A1
- Screening of nucleic acid agents via particle display12 May 2016US 2016/0130575 A1The Regents of the University of California
- Library Compositions and Methods for Acyclic Identification of Aptamers17 Sep 2015US 2015/0259673 A9Aptamatrix, Inc.
- Library Compositions and Methods for Acyclic Identification of Aptamers22 Aug 2013US 2013/0217582 A1Aptamatrix, Inc.
Most cited
By later US patents
- Systematic evolution of ligands exponential enrichment: blended selex113US 6,083,696 ANeXstar Pharmaceuticals, Inc. · 2000
- Systematic evolution of ligands by exponential enrichment: chemi-SELEX29US 5,998,142 ANeXstar Pharmaceuticals, Inc. · 1999
- Tenascin-C nucleic acid ligands12US 6,232,071 B1Gilead Sciences, Inc. · 2001
- Tenascin-C nucleic acid ligands4US 6,596,491 B2Gilead Sciences, Inc. · 2003